The Akkermansia Company
0664.529.083 · rovalta.com · 26/09/2026
ACTIVE
The Akkermansia Company
Financial year 2024 · Closed on 31/12/2024
Net result-3,6 M €+27,4 %over 1 year
Gross margin-1,5 M €+62,5 %over 1 year
Equity6,7 M €-36,1 %over 1 year
Workforce3,5 ETP-14,6 %over 1 year
Overview
Identity
Source · BCE/KBOThe Akkermansia Company is a Public limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 3,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0664.529.083
- Incorporation
- 11/10/2016
- Legal form
- Public limited company
- Registered office
- Rue Granbonpré 11
1435 Mont-Saint-Guibert · WallonieSee on map - Contributed capital
- 27 014 215,78 €
- Latest accounts
- 31/12/2024
- Average workforce
- 3,5 ETP
Activities (NACE)
Joint committees (1)
- 207
Signals
Solid equityGood liquidityHealthy social debts
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,5 M € | +62.5% | -4 M € | -21.7% | -3,3 M € | -50.8% | -2,2 M € | -45.6% | -1,5 M € |
| EBITDA | -2,9 M € | +32.7% | -4,4 M € | -16.8% | -3,7 M € | -38.7% | -2,7 M € | -27.9% | -2,1 M € |
| Operating result | -3,6 M € | +31.5% | -5,2 M € | -20.1% | -4,3 M € | -25.0% | -3,5 M € | -4.6% | -3,3 M € |
| Net result | -3,6 M € | +27.4% | -5 M € | -18.7% | -4,2 M € | -26.5% | -3,3 M € | -22.8% | -2,7 M € |
| Balance sheet | |||||||||
| Equity | 6,7 M € | -36.1% | 10,4 M € | +56.9% | 6,6 M € | -42.3% | 11,5 M € | +36.0% | 8,4 M € |
| Total assets | 18,6 M € | +38.8% | 13,4 M € | +44.8% | 9,3 M € | -27.9% | 12,9 M € | +27.5% | 10,1 M € |
| Cash | 6,6 M € | +61.1% | 4,1 M € | +758% | 478,2 k € | -92.6% | 6,4 M € | +76.4% | 3,6 M € |
| Debts | 11,9 M € | +293% | 3 M € | +14.4% | 2,6 M € | +93.9% | 1,4 M € | -16.6% | 1,6 M € |
| Other | |||||||||
| Workforce | 3,5 ETP | -14.6% | 4,1 ETP | -14.6% | 4,8 ETP | -20.0% | 6,0 ETP | -24.1% | 7,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20249 active · 41 ended
Active mandates
Active
Active
John Agwunobi
ActiveAlopekos Holding BV
ActiveInnovation Industries Fund Coöperatief UA
ActiveSeventure Partners
ActiveActive
Active
Ended mandates
Ended
John Agwunobi
EndedAlopekos Holding BV
EndedInnovation Industries Fund Coöperatief UA
EndedOther companies at this address
Rue Granbonpré 11 1435 Mont-Saint-Guibert| Company | CBE no. |
|---|---|
Ascend Performance Materials● Active | 0810.113.316 |
| 1012.379.397 | |
AUDANE INVEST● Active | 0816.921.429 |
BiocSol● Active | 1003.683.546 |
CEDRIC CLAERHOUDT● Active | 0477.799.927 |
Cellaïon● Liquidation | 0764.522.425 |
| 0859.906.087 | |
Cronos Sud● Active | 1014.190.824 |
DE SMET AGRO● Active | 0402.951.757 |
| 0438.987.752 | |
FLEXSO BRUSSELS● Active | 0898.889.892 |
Keiro● Active | 0681.490.821 |
NOVADIP BIOSCIENCES● Active | 0535.575.602 |
PARLYM BELGIUM● Active | 1028.144.372 |
PARSMET MANAGEMENT● Active | 1025.167.858 |
PROMETHERA BIOSCIENCES● Bankrupt | 0809.788.365 |
TFP IMMO● Active | 1032.940.330 |
THE TORREFACTORY PROJECT● Active | 0679.686.720 |
Tools4Patient● Active | 0534.842.954 |
VAT Group Ascend● Active | 1002.911.308 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/07/2025 | 16/08/2024 | 15/06/2023 | 07/07/2022 | 30/06/2021 | 10/06/2020 |
| General meeting | 14/05/2025 | 08/05/2024 | 11/05/2023 | 08/06/2022 | 12/05/2021 | 13/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 14/05/2025 | 30/07/2025 | French | |
| Abridged model | 31/12/2023 | 08/05/2024 | 16/08/2024 | French | |
| Abridged model | 31/12/2022 | 11/05/2023 | 15/06/2023 | French | |
| Abridged model | 31/12/2021 | 08/06/2022 | 07/07/2022 | French | |
| Abridged model | 31/12/2020 | 12/05/2021 | 30/06/2021 | French | |
| Abridged model | 31/12/2019 | 13/05/2020 | 10/06/2020 | French | |
| Abridged model | 31/12/2018 | 08/05/2019 | 05/06/2019 | French | |
| Abridged model | 31/12/2017 | 09/05/2018 | 28/06/2018 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20249 active · 41 ended
Active mandates
Active
Active
John Agwunobi
ActiveAlopekos Holding BV
ActiveInnovation Industries Fund Coöperatief UA
ActiveSeventure Partners
ActiveActive
Active
Ended mandates
Ended
John Agwunobi
EndedAlopekos Holding BV
EndedInnovation Industries Fund Coöperatief UA
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares21/11/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates20/08/2025DEMISSIONS, NOMINATIONS
- Other09/07/2025DIVERS
- Mandates09/07/2025DEMISSIONS, NOMINATIONS
- Capital / shares07/07/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Other17/04/2025DIVERS
- Mandates25/07/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates24/01/2024DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-3,6 M €↑
- 2023Annual accounts 2023-5 M €↓
- 2022Annual accounts 2022-4,2 M €↓
- 2022Name changeThe Akkermansia Company
- 2021Annual accounts 2021-3,3 M €↓
- 2021Name changeA-MANSIA BIOTECH
- 2020Annual accounts 2020-2,7 M €↓
- 2019Annual accounts 2019-1,6 M €↓
- 2018Annual accounts 2018-1,4 M €↓
- 2017Annual accounts 2017-206,8 k €
- 11/10/2016IncorporationPublic limited company